Emil Pharmaceutical Industries

Emil Pharmaceutical Industries is an established Indian pharmaceutical contract development and manufacturing organization (CDMO) and contract manufacturing organization (CMO) founded in 1986 and headquartered in Mumbai. The company specializes in the development, manufacturing, and marketing of a wide range of pharmaceutical, nutraceutical, and over-the-counter (OTC) formulations, including tablets, capsules, dry powders, creams, ointments, and oral liquids. Emil operates multiple state-of-the-art manufacturing facilities in Tarapur, Maharashtra, which are WHO-GMP certified and cater to major multinational pharmaceutical companies such as Pfizer, Merck, GSK, Abbott, and Novartis. In 2023, the company secured a significant investment of INR 150 crore from Somerset Indus Capital Partners to fund its capacity expansion, modernization, and global market footprint.